Priority Date: 13.07.12 (GB 20120012512)

IMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY

  • Application ID: EP13739376
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
1141.04
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) J A Kemp is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 190 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 13.07.2012 - Priority Date (GB 20120012512)
  • 16.01.2014 - Publication A1 (WO2014009295)
  • 20.05.2015 - Publication A1 (EP2872508)